The Challenge in Subtyping Cardiac Amyloidosis with Immunohistochemistry Staining: A Case Report.
作者信息
Hung Yi-Hsin, Tien Feng-Ming, Shun Chia-Tung, Cheng Mei-Fang, Tsai Cheng-Hsuan, Lin Yen-Hung
机构信息
Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine.
Cardiovascular Center.
出版信息
Acta Cardiol Sin. 2025 May;41(3):426-430. doi: 10.6515/ACS.202505_41(3).20250106D.
Abstract
摘要
相似文献
1
The Challenge in Subtyping Cardiac Amyloidosis with Immunohistochemistry Staining: A Case Report.免疫组织化学染色对心脏淀粉样变性进行亚型分类的挑战：一例报告
Acta Cardiol Sin. 2025 May;41(3):426-430. doi: 10.6515/ACS.202505_41(3).20250106D.
2
Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing.强转甲状腺素蛋白免疫染色：心脏淀粉样变性分型的潜在陷阱。
Am J Surg Pathol. 2011 Nov;35(11):1685-90. doi: 10.1097/PAS.0b013e3182263d74.
3
A More Accurate Approach to Amyloid Detection and Subtyping: Combining in situ Congo Red Staining and Immunohistochemistry.一种更精确的淀粉样蛋白检测和分型方法：原位刚果红染色与免疫组化相结合。
Pathobiology. 2017;84(1):49-55. doi: 10.1159/000447304. Epub 2016 Aug 3.
4
Subtyping of cardiac amyloidosis by mass spectrometry-based proteomics of endomyocardial biopsies.通过心内膜心肌活检的基于质谱的蛋白质组学对心脏淀粉样变性进行亚型分类。
Amyloid. 2023 Mar;30(1):96-108. doi: 10.1080/13506129.2022.2127088. Epub 2022 Oct 9.
5
Classification of amyloid deposits in diagnostic cardiac specimens by immunofluorescence.通过免疫荧光对诊断性心脏标本中的淀粉样沉积物进行分类。
Cardiovasc Pathol. 2009 Jul-Aug;18(4):205-16. doi: 10.1016/j.carpath.2008.05.004. Epub 2008 Jul 11.
6
How to diagnose amyloidosis.如何诊断淀粉样变性。
Intern Med J. 2014 Jan;44(1):7-17. doi: 10.1111/imj.12288.
7
[Classification of cardiac amyloidosis: an immunohistochemical analysis].[心脏淀粉样变性的分类：免疫组织化学分析]
Zhonghua Bing Li Xue Za Zhi. 2018 Feb 8;47(2):105-109. doi: 10.3760/cma.j.issn.0529-5807.2018.02.005.
8
F-Florbetaben PET/CT for the Diagnosis and Subtyping of Cardiac Amyloidosis: A Case Series and Review of the Literature.F-氟代硼替佐米正电子发射断层显像/计算机断层扫描用于心脏淀粉样变性的诊断和亚型分类：病例系列及文献综述
Acta Cardiol Sin. 2024 Sep;40(5):635-643. doi: 10.6515/ACS.202409_40(5).20240617D.
9
Pilot Study on the Use of Attenuated Total Reflectance-Fourier Transform Infrared Spectroscopy for Diagnosing and Characterizing Cardiac Amyloidosis.衰减全反射傅里叶变换红外光谱在诊断和特征化心脏淀粉样变性中的应用的初步研究。
Int J Mol Sci. 2024 Aug 29;25(17):9358. doi: 10.3390/ijms25179358.
10
Paraffin Immunofluorescence Increases Light-Chain Detection in Extra-Renal Light Chain Amyloidosis and Other Light-Chain-Associated Diseases.石蜡免疫荧光可增加肾脏外轻链淀粉样变性和其他与轻链相关疾病的轻链检出率。
Arch Pathol Lab Med. 2021 Mar 1;145(3):352-358. doi: 10.5858/arpa.2020-0018-OA.
本文引用的文献
1
Histological Typing in Patients With Cardiac Amyloidosis: JACC Review Topic of the Week.《伴有心脏淀粉样变性患者的组织学类型：JACC 本周综述专题》
J Am Coll Cardiol. 2024 Mar 19;83(11):1085-1099. doi: 10.1016/j.jacc.2024.01.010.
2
2023 Expert Consensus of the Taiwan Society of Cardiology on the Diagnosis and Treatment of Cardiac Amyloidosis.台湾心脏病学会2023年心脏淀粉样变诊断与治疗专家共识
Acta Cardiol Sin. 2023 Jul;39(4):511-543. doi: 10.6515/ACS.202307_39(4).20230610A.
3
2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee.2023年美国心脏病学会关于心脏淀粉样变性患者综合多学科护理的专家共识决策路径：美国心脏病学会解决方案集监督委员会报告
J Am Coll Cardiol. 2023 Mar 21;81(11):1076-1126. doi: 10.1016/j.jacc.2022.11.022. Epub 2023 Jan 23.
4
Two Kinds of Cardiac Amyloidosis in One Patient: A Case Report.一名患者患两种类型的心脏淀粉样变性：病例报告
Acta Cardiol Sin. 2022 Nov;38(6):806-809. doi: 10.6515/ACS.202211_38(6).20220425B.
5
Prevalence and Risk Factors of Cardiac Amyloidosis in Heart Failure: A Systematic Review and Meta-Analysis.心力衰竭中心脏淀粉样变的患病率及危险因素：系统评价和荟萃分析。
Heart Lung Circ. 2022 Nov;31(11):1450-1462. doi: 10.1016/j.hlc.2022.08.002. Epub 2022 Sep 20.
6
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases.心脏淀粉样变性的诊断与治疗：欧洲心脏病学会心肌与心包疾病工作组的立场声明
Eur Heart J. 2021 Apr 21;42(16):1554-1568. doi: 10.1093/eurheartj/ehab072.
7
Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR).系统性转甲状腺素蛋白淀粉样变性（ATTR）中的意义未明的单克隆丙种球蛋白病。
Amyloid. 2018 Mar;25(1):62-67. doi: 10.1080/13506129.2018.1436048. Epub 2018 Feb 9.
8
Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients.免疫组织化学在系统性淀粉样变性分类中的应用：对 117 例患者的系统研究。
Blood. 2012 Jan 12;119(2):488-93. doi: 10.1182/blood-2011-06-358507. Epub 2011 Nov 21.
9
Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing.强转甲状腺素蛋白免疫染色：心脏淀粉样变性分型的潜在陷阱。
Am J Surg Pathol. 2011 Nov;35(11):1685-90. doi: 10.1097/PAS.0b013e3182263d74.
10
Pitfalls in the diagnosis of primary amyloidosis.原发性淀粉样变诊断中的陷阱。
Clin Lymphoma Myeloma Leuk. 2010 Jun;10(3):177-80. doi: 10.3816/CLML.2010.n.027.
Zotero 插件